VistA-internationalization/TranslationSpreadsheets/WV-DIALOG-0233.txt

308 lines
12 KiB
Plaintext

English French Notes Complete/Exclude
ABDOMINAL INFECTION..............: NA, no treatment
ABSCESS..........................: NA, no treatment
ADMISSION FOR NEUTROPENIA........: NA, no treatment
ANASTOMOTIC DEHISCENCE...........: NA, no treatment
BLEEDING/HEMATOMA................: NA, no treatment
DEHYDRATION......................: NA, no treatment
DIARRHEA.........................: NA, no treatment
EARLY BOWEL OBSTRUCTION..........: NA, no treatment
PERINEAL INFECTION...............: NA, no treatment
PNEUMONIA........................: NA, no treatment
PROCTITIS........................: NA, no treatment
PULMONARY EMBOLISM...............: NA, no treatment
RADIATION ENTERITIS..............: NA, no treatment
STOMA COMPLICATION...............: NA, no treatment
URINARY TRACT INFECTION..........: NA, no treatment
POSTOPERATIVE DEATH W/I 30 DAYS: NA, no surgery
763 ADDITIONAL SURGICAL PROCEDURES..
764 LAPAROSCOPY USED DURING SURGERY.
765 METHOD OF ANASTOMOSIS...........
766 DIST OF ANASTOMOSIS FROM DENTATE
59 RESIDUAL PRIMARY TUMOR..........
769 PATHOLOGICAL STATUS...........
770 ABDOMINAL INFECTION...........
772 ADMISSION FOR NEUTROPENIA.....
773 ANASTOMOTIC DEHISCENCE........
776 EARLY BOWEL OBSTRUCTION.......
777 PERINEAL INFECTION............
780 PULMONARY EMBOLISM............
781 RADIATION ENTERITIS...........
782 STOMA COMPLICATION............
783 URINARY TRACT INFECTION.......
441 POSTOPERATIVE DEATH W/I 30 DAYS.
DATE RADIATION STARTED..........:
DATE RADIATION THERAPY ENDED....: 00/00/0000
ENDOCAVITARY RADIATION..........: None
INTRA-OPERATIVE RAD THERAPY.....: No
PRIMARY TUMOR RAD DOSE W BOOST..: No radiation therapy
NUMBER OF RADIATION TREATMENTS..: None
DATE RADIATION THERAPY ENDED....: 99/99/9999
ENDOCAVITARY RADIATION..........: Unknown
INTRA-OPERATIVE RAD THERAPY.....: Unknown
PRIMARY TUMOR RAD DOSE W BOOST..: Unknown if received radiation therapy
NUMBER OF RADIATION TREATMENTS..: Unknown if radiation given
361 DATE RADIATION THERAPY ENDED....
784 ENDOCAVITARY RADIATION..........
785 INTRA-OPERATIVE RAD THERAPY.....
786 PRIMARY TUMOR RAD DOSE W BOOST..
787 NUMBER OF RADIATION TREATMENTS..
DATE CHEMOTHERAPY STARTED.......:
ADJUVANT CHEMO W BEAM RADIATION.: No concomitant treatment
ADJUVANT THERAPY:
DURATION OF ADJUVANT THERAPY....: No adjuvant therapy
COMPLETED DURATION OF THERAPY...: No (0-1 cycle)
ADJUVANT CHEMO W BEAM RADIATION.: Unknown if therapy concomitant
DURATION OF ADJUVANT THERAPY....: Unknown if therapy given
COMPLETED DURATION OF THERAPY...: Unknown if therapy given
788 ADJUVANT CHEMO W BEAM RADIATION.
794 DURATION OF ADJUVANT THERAPY....
795 COMPLETED DURATION OF THERAPY...
WERE OTHER REFERRALS MADE
TABLE V - QUALITY OF LIFE
WERE OTHER REFERRALS MADE:
796 NUTRITIONAL CONSULTATION
797 OCCUPATIONAL THERAPY....
563 PHYSICAL THERAPY........
798 OSTOMY CONSULTATION.....
70DATE OF FIRST RECURRENCE......
71TYPE OF FIRST RECURRENCE......
DATE OF LAST CONTACT OR DEATH:
15VITAL STATUS.................
CANCER STATUS................:
81COMPLETED BY.................
82REVIEWED BY CANCER COMMITTEE.
10. FAMILY HISTORY OF COLORECTAL CA..:
11. PERSONAL HISTORY OF COLORECTAL CA:
12. MULTI 1997 COLON/RECTUM PRIMARIES:
13. PERSONAL HISTORY OF NON-COLORECTAL CANCER:
PROSTATE.........:
STOMACH..........:
THYROID..........:
UTERUS...........:
OVARIAN CARCINOMA:
OTHER............:
14. PREVIOUS TAH/BSO.................:
15. OTHER PRIOR CONDITIONS:
PRIOR POLYPS.....:
POLYPS...........:
17. DURATION OF SIGNS/SYMPTOMS PRESENT AT INITIAL DIAGNOSIS (months):
BOWEL OBSTRUCTION..............:
CHANGE IN BOWEL HABIT..........:
EMER PRESENTATION-OBSTRUCTION..:
OCCULT BLOOD ONLY IN STOOL.....:
RECTAL BLEEDING (MELENA).......:
18. INITIAL METHODS OF DIAGNOSIS:
SCREENING DIGITAL RECTAL EXAM..:
SCREENING PHYSICAL EXAM........:
19. REASON LEADING TO EVENTUAL DX....:
20. DIAGNOSTIC EVALUATION:
BARIUM ENEMA, DOUBLE CONTRAST..:
BARIUM ENEMA, SINGLE CONTRAST..:
BARIUM ENEMA, NOS..............:
BIOPSY OF PRIMARY SITE.........:
BIOPSY OF METASTATIC SITE......:
CT SCAN OF CHEST...............:
CT SCAN OF LIVER...............:
CT SCAN OF PRIMARY SITE........:
CHEST ROENTGENOGRAM............:
DIGITAL RECTAL EXAM............:
FLEXIBLE SIGMOIDOSCOPY.........:
INTRAVENOUS PYELOGRAM..........:
SERUM-LIVER FUNCTION TEST......:
STOOL GUAIAC (OCCULT BLOOD)....:
21. LEVEL OF TUMOR BY ENDOSCOPIC EXAM:
22. LEVEL OF RECTAL TUMOR............:
23. DATE OF INITIAL DIAGNOSIS........:
24. PRIMARY SITE.....................:
25. HISTOLOGY/26. BEHAVIOR CODE......:
28. DIAGNOSTIC CONFIRMATION..........:
Print Colorectal Cancer PCE
PCE Study of Colorectal Cancer
29. SIZE OF TUMOR (mm)...............:
30. REGIONAL NODES EXAMINED..........:
31. REGIONAL NODES POSITIVE..........:
32. AJCC CLINICAL STAGE (cTNM):
AJCC STAGE.....................:
33. AJCC PATHOLOGIC STAGE (pTNM):
34. STAGED BY:
CLINICAL STAGE.................:
PATHOLOGIC STAGE...............:
35. MARGIN OF RESECTION:
PROXIMAL MARGIN................:
DISTAL MARGIN..................:
RADIAL MARGIN..................:
36. DISTANCE TO MUCOSAL MARGIN.......:
37. DISTANCE TO RADIAL MARGIN........:
38. BLOOD VESSEL/LYMPHATIC INVASION..:
39. EXTRAMURAL VENOUS INVASION.......:
40. PROMINENT LYMPHOID INFILTRATE....:
41. PHYSICIAN PROVIDING TREATMENT....:
42. FIRST COURSE OF TREATMENT DATE...:
43. DATE OF INPATIENT ADMISSION......:
44. DATE OF INPATIENT DISCHARGE......:
45. NON CANCER-DIRECTED SURGERY DATE.:
46. NON CANCER-DIRECTED SURGERY......:
47. SURGERY OF PRIMARY SITE DATE.....:
48. SURGERY OF PRIMARY SITE..........:
49. ADDITIONAL SURGICAL PROCEDURES...:
50. LAPAROSCOPY USED DURING SURGERY..:
51. METHOD OF ANASTOMOSIS............:
52. DIST OF ANASTOMOSIS FROM DENTATE.:
53. RESIDUAL PRIMARY TUMOR...........:
54. OTHER SURGERY:
PATHOLOGICAL STATUS............:
55. COMPLICATIONS AFTER FIRST COURSE OF TREATMENT:
ABDOMINAL INFECTION......:
PERINEAL INFECTION.......:
PNEUMONIA................:
ADMISSION FOR NEUTROPENIA:
PROCTITIS................:
ANASTOMOTIC DEHISCENCE...:
PULMONARY EMBOLISM.......:
RADIATION ENTERITIS......:
STOMA COMPLICATION.......:
URINARY TRACT INFECTION..:
EARLY BOWEL OBSTRUCTION..:
56. POSTOPERATIVE DEATH W/I 30 DAYS:
57. DATE RADIATION STARTED...........:
58. DATE RADIATION THERAPY ENDED.....:
59. ENDOCAVITARY RADIATION...........:
60. INTRA-OPERATIVE RAD THERAPY......:
61. PRIMARY TUMOR RAD DOSE W BOOST...:
62. NUMBER OF RADIATION TREATMENTS...:
64. DATE CHEMOTHERAPY STARTED........:
65. ADJUVANT CHEMO W BEAM RADIATION..:
66. ADJUVANT THERAPY:
CPT 11.............:
TAXOL..............:
OTHER..............:
67. DURATION OF ADJUVANT THERAPY.....:
68. COMPLETED DURATION OF THERAPY....:
69. WERE OTHER REFERRALS MADE:
NUTRITIONAL CONSULTATION.......:
OCCUPATIONAL THERAPY...........:
PHYSICAL THERAPY...............:
OSTOMY CONSULTATION............:
70. DATE OF FIRST RECURRENCE..........:
71. TYPE OF FIRST RECURRENCE..........:
72. DATE OF LAST CONTACT OR DEATH....:
73. VITAL STATUS.....................:
74. CANCER STATUS....................:
75. COMPLETED BY.....................:
76. REVIEWED BY CANCER COMMITTEE.....:
Deleting data from the following fields...
SURGICAL DX/STAGING PROC
SURGICAL DX/STAGING PROC DATE
SURGERY OF PRIMARY (R)
SURGICAL APPROACH (R)
SURGERY OF PRIMARY (F)
SURGERY OF PRIMARY DATE
SURGICAL MARGINS
DATE OF SURGICAL DISCHARGE
REASON FOR NO SURGERY
SURGERY OF PRIMARY SITE
SURGERY OF PRIMARY SITE DATE
SCOPE OF LN SURGERY (R)
NUMBER OF LN REMOVED (R)
SCOPE OF LN SURGERY (F)
SCOPE OF LYMPH NODE SURG DATE
SURG PROC/OTHER SITE (R)
SURG PROC/OTHER SITE (F)
SURG PROC/OTHER SITE DATE
DATE RADIATION STARTED
LOCATION OF RADIATION TX
RADIATION TREATMENT VOLUME
REGIONAL TREATMENT MODALITY
REGIONAL DOSE:cGy
BOOST TREATMENT MODALITY
BOOST DOSE:cGy
NUMBER OF TXS TO THIS VOLUME
RADIATION/SURGERY SEQUENCE
DATE RADIATION ENDED
REASON FOR NO RADIATION
TEXT-RX-RADIATION OTHER
CHEMOTHERAPY DATE
REASON FOR NO CHEMOTHERAPY
HORMONE THERAPY
HORMONE THERAPY DATE
REASON FOR NO HORMONE THERAPY
IMMUNOTHERAPY DATE
HEMA TRANS/ENDOCRINE PROC
HEMA TRANS/ENDOCRINE PROC DATE
OTHER TREATMENT
OTHER TREATMENT DATE
PALLIATIVE PROCEDURE @FAC
SURGICAL DX/STAGING @FAC
SURGICAL DX/STAGING @FAC DATE
SURGERY OF PRIMARY @FAC (R)
SURGERY OF PRIMARY @FAC (F)
SURGERY OF PRIMARY @FAC DATE
SCOPE OF LN SURGERY @FAC (R)
NUMBER OF LN REMOVED @FAC (R)
SCOPE OF LN SURGERY @FAC (F)
SCOPE OF LN SURGERY @FAC DATE
SURG PROC/OTHER SITE @FAC (R)
SURG PROC/OTHER SITE @FAC (F)
SURG PROC/OTHER SITE @FAC DATE
RADIATION @FAC DATE
CHEMOTHERAPY @FAC DATE
HORMONE THERAPY @FAC
HORMONE THERAPY @FAC DATE
IMMUNOTHERAPY @FAC DATE
OTHER TREATMENT @FAC
OTHER TREATMENT @FAC DATE
STATE AT DX = YY (
POSTAL CODE AT DX must be 888888888
STATE AT DX = ZZ (
POSTAL CODE AT DX must be 999999999
REPORTING HOSPITAL = FACILITY REFERRED FROM
REPORTING HOSPITAL = FACILITY REFERRED TO
CLASS OF CASE =
FACILITY REFERRED FROM may not be blank
DATE OF FIRST CONTACT..:
later than
SURGERY OF PRIMARY SITE DATE.:
RADIATION DATE...............:
RADIATION THERAPY TO CNS DATE:
CHEMOTHERAPY DATE............:
HORMONE THERAPY DATE.........:
IMMUNOTHERAPY DATE...........:
OTHER TREATMENT DATE.........:
earlier than
DATE DX......................:
TYPE OF REPORTING SOURCE = 6 (
CLASS OF CASE must be 5 (Dx at autopsy)
CLASS OF CASE = 5 (
TYPE OF REPORTING SOURCE must be 6 (Autopsy only)
TYPE OF REPORTING SOURCE = 7 (
DIAGNOSTIC CONFIRMATION must be 9 (Unk if microscopically confirmed)
DIAGNOSTIC CONFIRMATION must be 1 (Pos histology) or
6 (Direct visualization)
is a paired site
LATERALITY must be provided for specified paired organs/sites
NOTE: If NASAL CARTILAGE or NASAL SEPTUM, override this warning.
NOTE: If CARINA, override this warning.
NOTE: If STERNUM, override this warning.
NOTE: If SACRUM, COCCYX or SYMPHYSIS PUBIS, override this warning.
is an unpaired site
LATERALITY must be 0 (Not a paired site)
BEHAVIOR CODE = 2 (In situ)
SUMMARY STAGE =
BEHAVIOR CODE and SUMMARY STAGE confict
BEHAVIOR CODE = 3 (Malignant)
SUMMARY STAGE = 0 (In situ)
HISTOLOGY =
TYPE OF REPORTING SOURCE =
SUMMARY STAGE must be 7 (Distant Mets/systemic disease)
GRADE/DIFFERENTIATION must be 1 (Grade I)
GRADE/DIFFERENTIATION must be 2 (Grade II)
GRADE/DIFFERENTIATION must be 4 (Grade IV)
GRADE/DIFFERENTIATION must be: 3 (Grade III)
7 (Null cell)
#################### #################### ####################
#################### #################### ####################
#################### #################### ####################
#################### #################### ####################
#################### #################### ####################